CANF
Can-Fite BioPharma
CANF
CANF
2 hedge funds and large institutions have $51K invested in Can-Fite BioPharma in 2013 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$44K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$7K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $44K | 7,328 | +7,328 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $7K | 1,134 | +1,134 | New |
|